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Strengths and limitations of this study
 Ź This is a detailed evaluation of a digitally enabled 
care system that aims to provide accessible, spe-
cialist holistic care to patients with motor neuron 
disease and their carers.
 Ź The use of mixed methods provided an in-depth 
understanding of the processes involved in the new 
care service, the potential value of telehealth in mo-
tor neuron disease and factors that are likely to in-
luence its use, implementation and success.
 Ź This was a small, single-centre study using only one 
nurse to deliver the intervention.
ABSTRACT
Objectives To evaluate the processes involved in using 
a novel digitally enabled healthcare system (telehealth in 
motor neuron disease (TiM)) in people living with motor 
neuron disease (MND) and their informal carers. We 
examined TiM implementation, potential mechanisms of 
impact and contextual factors that might inluence TiM 
implementation or impact.
Design An 18-month, single-centre process evaluation 
within a randomised, pilot and feasibility study.
Intervention TiM plus usual care versus usual care alone.
Setting A specialist UK MND care centre.
Participants 40 patients with MND and 37 primary 
informal carers.
Primary and secondary outcome measures Patient, 
carer and staff outcomes and experiences using 
semistructured interviews. Descriptive data on 
implementation and use of TiM.
Results The TiM was acceptable and accessible to 
patients, carers and staff. Intervention uptake and 
adherence were good: 14 (70%) patients completed a 
TiM session at least fortnightly. Barriers to TiM use (such 
as technology experience and disability) were overcome 
with well-designed technology and face-to-face training. 
Reported potential beneits of TiM included improved 
communication and care coordination, reassurance, 
identiication of complications and the potential for TiM to 
be an alternative or addition to clinic. Beneits depended 
on patients’ current level of needs or disability. The 
main challenges were the large number of alerts that 
were generated by TiM, how the clinicians responded 
to these alerts and the mismatch between patient/carer 
expectations and nurses actions. This could be improved 
by better communication systems and adjusting the alerts 
algorithm.
Conclusion TiM has the potential to facilitate access to 
specialist care, but further iterative developments to the 
intervention and process evaluations of the TiM in different 
services are required.
Trial identiier number ISRCTN26675465.
BACkgROunD
Motor neuron disease (MND) causes progres-
sive muscle paralysis, severe disability and even-
tually death within on average 2 to 4 years.1 
Attendance at a specialist multidisciplinary 
clinic (MDC) is associated with improved 
survival and use of assistive aids, devices 
and proven therapies.2–7 Patients face many 
barriers accessing specialist services, meaning 
many patients fail to gain the full benefit from 
these services.8 There is some evidence that 
digital-enabled technologies can improve 
access to specialist care.9 Video-consultation 
(telemedicine) is used in some centres and 
appears to be feasible and acceptable.10–14 
However, between consultations, changes in 
patients’ condition may not be recognised. 
There are several technologies in develop-
ment that can frequently record aspects of 
MND progress (telehealth) such as speech 
or hand function. They have predominately 
been developed for research, but telehealth 
could be used for clinical care purposes.15–18 
No digital system has yet been evaluated that 
can monitor the full range of problems faced 
by patients with MND in order to detect and 
act on issues that arise in a timely manner.
There also remains a need to develop inter-
ventions to support carers of those with MND. 
Medical interventions such as non-invasive 
ventilation and gastrostomy feeding require 
carers to conduct complex tasks with little 
training.19 Carers report that these interven-
tions are associated with increased physical 
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strain and carer time.20–22 Provision of disease-specific 
information and signposting to external support services 
have been identified as helpful23 24 and while one small 
study of intensive case management reported positive 
feedback,25 another showed no improvement in carer 
strain.26
We employed a user-centred design process to develop 
the telehealth in MND (TiM) telehealth system.27 This 
allows patients and carers to send information about 
their condition to the specialist care team.27 Early 
testing has already been conducted with a small number 
of potential users, but further testing in the clinical 
environment was required.27 Telehealth services are 
complex interventions, consisting of different compo-
nent parts and whose success relies on the context and 
individual behaviours of those using and delivering the 
intervention.28 Clinical trials of complex interventions 
such as telehealth face problems with patient and staff 
engagement and often lack of understanding of how 
the intervention is used, what works and for whom.29–31 
People living with MND and their carers face addi-
tional barriers to using digitally enabled care due to 
their disability and age. The complexity of the disease 
and the holistic aims of care in this terminal disease 
mean telehealth systems will need to differ from more 
simplistic, target-driven care systems (such as blood 
pressure management). With these challenges in mind, 
the Medical Research Council recommend that devel-
opment of a telehealth service is iterative with learning 
from development, piloting, evaluation and implemen-
tation informing each step.32
Aim of the study
We conducted a pilot and feasibility randomised 
controlled trial (RCT) in patients and carers of usual care 
plus TiM versus usual care. The results of the pilot and 
feasibility trial are described in a parallel publication.33 
In this paper, we describe the process evaluation,34 which 
aimed to gain a deeper understanding of the use of the 
TiM system.
We aimed to observe the processes that occurred when 
TiM was used to deliver specialist multidisciplinary care 
in MND exploring:
 Ź TiM technology set-up and delivery.
 Ź Participants’ adherence to TiM.
 Ź Participants’ attitudes towards TiM.
 Ź Clinicians’ attitudes towards TiM.
 Ź Potential impacts of the TiM on participants and staff 
(both intended and unintended).
 Ź The mechanisms and contextual factors that may 
affect the impact and implementation on a larger 
scale.
We also aimed to:
 Ź Identify problems with TiM.
 Ź Begin to implement and evaluate improvements.
 Ź Identify further improvements and uses of the TiM.
MeThODS
Study design
The methods of the pilot and feasibility RCT are described 
in a parallel publication.33 A supplementary file (online 
supplementary file) contains the TiM protocol, topic 
guides and statistics analysis plan. In brief, patients with 
MND (amyotrophic lateral sclerosis, progressive muscular 
atrophy and primary lateral sclerosis) and their primary 
informal carer currently receiving care from the Sheffield 
MDC were recruited and randomised to receive either 
the intervention (TiM plus usual care) or the control 
(usual care alone). Participants were followed up for 
between 6 and 18 months. Usual care involved invitations 
to the MDC 2 to 6 monthly plus access between visits to 
the multidisciplinary team (MDT) via an MND specialist 
nurse by telephone, email or through liaison with other 
healthcare professionals.
ethics and consent
Written or witnessed verbal consent was gained from 
patients, carers and the telehealth nurse prior to 
randomisation.
Intervention
A detailed description of TiM has been published.27 The 
TiM patient/carer app contains a set of patient and carer 
questions assessing the disease progression, complica-
tions of MND, use of medical interventions and patient 
and carer well-being. The app was loaded onto a 7-inch 
Samsung Galaxy tablet with 3G internet. We asked partici-
pants to complete the questions weekly or more frequently 
if they desired. The results were sent using the internet to 
a clinical portal used by the MDC specialist nurse (the 
telehealth nurse) who had over 15 years experience of 
MND care. The portal assigned a red, amber or green 
flag to all the answers depending on a predetermined 
algorithm created by the TiM developers. The telehealth 
nurse was expected to review the answers and could liaise 
with specialists in the wider MDT and provide telephone 
advice. All patients and carers continued to receive usual 
care, Sheffield MDC appointments and telephone/email 
access to the telehealth nurse. Clinic appointments could 
not be postponed but could be expedited. The nurse was 
required to have a discussion with the patient, carer or 
clinician to confirm the accuracy of the information prior 
to making any clinical decisions. Also loaded onto the 
tablet were educational materials (known as the Knowl-
edge Centre) and within the app was a section where 
patients could make a list of issues the participant wished 
to discuss at clinic (the Problem List) and educational 
messages, which appeared between questions.
EH recruited participants at home. Participants were 
given the tablet and Wi-Fi-enabled standing weighing 
scales. They were given face-to-face training, written 
information, telephone and email support. EH contacted 
patients after 2 weeks if they did not submit a TiM session 
and visited at 1 and 6 months for interviews, which 
provided an opportunity to resolve technical issues. EH 
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trained clinicians to use the clinical portal in face-to-face 
training, which took approximately 10 minutes. During 
the trial, we gained feedback from users in order to 
improve the system. The trial started in October 2014, 
and one major change to the patient app and the clinical 
portal was implemented in October 2015.
Data collection
A detailed description of all data collection is described in 
the accompanying feasibility paper33 and in the protocol 
(online supplementary file). Patient-/carer-reported 
outcome measures were collected at 0, 3, 6, 12 and 18 
months using postal questionnaires. These assessed 
patient disability, depression, anxiety, quality of life and 
health utility. To gain a deeper understanding of the 
processes involved, we evaluated patient, carer and staff 
experiences of the TiM. Patients and carers completed 
satisfaction questionnaires using postal questionnaires at 
the same intervals. We also collected clinician-reported 
adverse events and health resource use using postal 
questionnaires.
We conducted semistructured interviews. Interviews 
were conducted by EH at baseline (control participants) 
and 1 and 6 months (intervention participants). Inter-
views with the telehealth nurse were conducted at 14 and 
18 months. The 18-month interview was conducted by an 
experienced qualitative researcher WB. Additionally, an 
interview with an MND specialist community nurse who 
cared for a number of participants in both treatment 
arms during the study was conducted at 18 months. Topic 
guides (online supplementary filepage 41) included 
participants’ experience of specialist MDC and commu-
nity care, attitudes towards technology and digitally 
enabled care, expectations and experiences using TiM, 
reasons for good and poor TiM usage, potential impacts 
TiM could have on MND care, and improvements and 
future applications of TiM. Early results and observa-
tions from the trial influenced the topic guides for later 
interviews. Interviews were audio-recorded, transcribed 
verbatim, checked by the interviewer and organised using 
NVivo.35 Thematic analysis was used.36 A triangulation 
process compared the quantitative and qualitative data to 
further understand and explain important, incongruent 
and unexpected observed phenomenon.37 EH conducted 
the analysis with supervision from WB. Results were 
presented to the trial management group and steering 
committee.
MDC physicians completed a satisfaction questionnaire 
(‘Shadow monitoring form’, see online supplementary 
file page 71) when they saw a patient in clinic using TiM 
capturing opinions on the accuracy, feasibility and accept-
ability of TiM. Field notes were also taken to describe any 
problems with TiM, solutions that were used and their 
outcomes. At the end of the trial, we downloaded all data 
collected by TiM into Excel. This contained the time and 
date of every session, all answers provided by patients and 
carers, all alerts generated by the system and all clinical 
notes made by the telehealth nurse. We used descriptive 
statistics to report the TiM use. We attempted to record 
the telehealth nurse’s time spent using TiM using diaries 
but these were incomplete. Instead, this was explored 
using interviews.
Patient and public involvement
During development of TiM27 and the protocol, we 
consulted patients, carers and the Sheffield MND 
Research Advisory group (a patient and public involve-
ment group). They reviewed the intervention, principles 
of the trial, trial design, outcome measures and partic-
ipant information leaflets and provided comments on 
their feasibility and accessibility. They were not involved 
in recruitment. Results of the study have been communi-
cated at various public meetings, through the Sheffield 
MND Research Advisory group and local branch of the 
MND Association and a lay summary will be circulated. 
Members of this group attended the trial steering and 
trial management groups. AQ was a member of the trial 
management group, provided advice on the research 
methods, interpretation of the data and dissemination 
and is a co-author on this paper.
ReSulTS
Participants
Forty patients and 37 informal carers (three patients had 
no carer) were recruited. Two TiM patients withdrew due 
to severe illness and one died before 6 months, the rest 
used TiM for between 6 and 18 months. Participant char-
acteristics are reported in full in the parallel paper.33 The 
patients broadly represented those attending an MDC 
including patients at all stages of disease (table 1). While 
patients’ use of digital technologies was common, some 
participants had little or no experience using technology. 
Thirty-eight (95%) patients had home broadband and 33 
(83%) had mobile internet reception.
TiM technology set-up and delivery
(Online supplementary data file tables 1–4)
All participants allocated the intervention received the 
TiM system and could use it using mobile or home broad-
band. Technical problems and solutions were all resolved 
and had little impact on the trial except the Wi-Fi-en-
abled scales, which were not found to be practical due to 
a lack of reliability connecting to the internet (table 2). At 
6 months, all the patients and 14 (93%) of the carers felt 
TiM was easy to use (figure 1). Fourteen (93%) patients 
and carers did not think the system was tiring and 13 
(87%) did not think the questions were distressing, nor 
the use of the system intrusive.
‘It’s so easy to do; it literally takes five minutes from 
home.’ Patient 317
Twenty-seven patients (68%) reported some difficulty 
using technology due to upper limb disability but 34 
(85%) could use the patient app independently (although 
they might need a carer to help charge the tablet). One 
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Table 1 Participant characteristics
Telehealth (n=20) Control (n=20)
Patient gender, male 14 (70%) 14 (70%)
Age (years)
Mean (SD), range
60.4 (11.7), 30–78 60.0 (10.0), 
39–73
Disease duration (months)
Mean (SD), range
53 (48), 12–197 46 (35), 7–123
King’s ALS clinical stage*
  1 3 (15%) 2 (10%)
  2 4 (20%) 5 (25%)
  3 5 (25%) 8 (40%)
  4 8 (40%) 5 (25%)
Use of the TiM app
  Independently 17 (85%) 17 (85%)
  Help from carer 1 (5%) 1 (5%)
  Patient instructs carer 2 (10%) 2 (15%)
Patient technology use†
  Daily 14 (70%) 18 (90%)
  Few times per week 3 (15%) 1 (5%)
  Once a week 1 (5%) 1 (5%)
  Every few weeks 0 (0%) 0 (0%)
  Never 2 (10%) 0 (0%)
 Telehealth (n=19) Control (n=18)
Carer gender, male 4 (21%) 5 (28%)
  Carer age (years)
  Mean (SD), range
59 (12), 42–84 60.8 (11), 38–73
Relationship to patient
  Partner 18 (95%) 16 (89%)
  Child 0 (0%) 1 (6%)
  Parent 1 (5%) 1 (6%)
Carer technology use†
  Daily 12 (67%) 16 (84%)
  Few times per week 1 (6%) 0 (0%)
  Once a week 1 (6%) 2 (11%)
  Every few weeks 0 (0%) 1 (5%)
  Never 4 (22%) 0 (0%)
*King’s stage 1 refers to patients with functional deicit in one 
domain, stage 2 refers to disability in two domains, stage 
3 refers to disability in three domains and stage 4 refers to 
patients requiring NIV and/or gastrostomy. King’s stage was 
calculated using the ALS-FRS-R scale at baseline.
†Technology use: computer, tablet, smart phone.
ALS-FRS-R, Amytrophic lateral sclerosis functional rating scale 
revised; NIV, Non-invasive ventilation; TiM, telehealth in motor 
neuron disease.
patient could use the app but during training it was 
noticed that his answers were not accurate (Patient 073). 
He was unable to communicate verbally and exhibited 
behaviours suggestive of mild cognitive deficits. In this 
case, he was happy for carers to help him use it.
Participants found face-to-face training important. 
Many were pleasantly surprised by their achievements.
‘I thought I wouldn’t be able to do it (laughter) but I 
can….’ Carer 228
The main perceived barrier was participants’ experi-
ence using technology.
‘…we’re quite happy to deal with it, as long as it 
wasn’t too techy’ Carer 062
Many participants (including those using technology 
daily) perceived themselves lacking an intrinsic ability to 
use technology, saying that they were ‘bad’ at it, thinking 
others were more ‘wired’ to using technology. They shared 
common attitudes towards their abilities, experience and 
approach to technology. They reported struggling to learn 
to use new technology finding it stressful and were fearful 
of making a mistake or breaking the device. They did not 
feel in control of technology, expressing frustration when 
technology did not ‘obey’ them. This meant they were 
not confident adapting to unfamiliar technology. They 
tended to use technology for a limited number of basic 
tasks, lacking confidence to problem solve when tech-
nology ‘went wrong’, relying instead on others. Some low 
users explained they never learnt, or did not see the need 
to use technology, particularly if their partner used it.
One couple (Patient 166) had no experience of tech-
nology and were highly critical of the perceived intrusion 
of technology in their lives. They described themselves 
as ‘technophobes’. However, they trusted their care team 
would provide them with a secure and safe system. Only 
one carer in his 80s (Carer 217) struggled to ‘catch on’, 
needing help from his partner. He had little prior expe-
rience with technology, and it was later noted that he 
had difficulties with language due to another medical 
condition.
Participant adherence to TiM
(Online supplementary data file tables 4–6)
Participants preferred to complete the TiM weekly (13, 
87% of patients; 8, 53% of carers). They reported that 
weekly sessions helped them remember to use the TiM. 
Some suggested they would complete TiM less frequently 
if nothing had changed. The telehealth nurse suggested 
that fortnightly information was sufficient to enable her 
to assess a patient’s progress and even less frequently for 
carers. Adherence was calculated by dividing the total 
number of sessions completed by the number of weeks 
participants were in the trial (figures 2 and 3). Fourteen 
(70%) patients and 10 (55%) carers completed TiM 
sessions on average, at least fortnightly. Thirteen (70%) 
carers completed sessions, on average, at least every 
3 weeks. Some participants who completed fewer sessions 
still continued to use TiM regularly. Adherence dropped 
during the study, but at 12 months 80% of patients were 
still using it weekly. The main reasons for low adher-
ence were forgetting, holidays and deterioration in their 
illness. A lack of feedback about the answers participants 
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Table 2 Technology problems encountered during the trial
Problem Solution adopted
Impact on the use of the 
TiM Recommendations for future TiM use
TiM Patient App software
  Poor inger dexterity Handheld stylus 
provided
85% used TiM 
independently.
Provide stylus to all patients.
Carer help to use 
device
Interview data suggested 
that help from carers was 
acceptable.
Encourage carer support.
  Dificulties entering 
login password
Telephone support Problem resolved with 
second TiM app release.
Provide face-to-face training.
Provide telephone technical support.
Login page redesigned No further problems 
reported.
Make local staff familiar with the software.
  Lack of conidence 
using the app or other 
features on the TiM
Face-to-face training
Partner/family helped
None: all participants could 
use the app.
Provide face-to-face training plus an 
additional contact after a few weeks to 
reinforce learning. Identify low conidence/
experience users and provide extra training.
  Patients not giving 
correct answers
Patient completing TiM 
with their family
Uncertain impact. Capacity assessment at recruitment. Check 
TiM answers in training and in clinic.
Tablet
  Tablet stored in place 
not accessible to 
patient
No solution available Interviews suggested that 
adherence was reduced for 
two patients.
Use patients’ own equipment where 
possible.
  Tablet battery drained, 
unable to switch on
Telephone advice No impact. Use patients’ own equipment. Familiarise 
local staff with hardware.
  Unexpected screens/ 
software updates
Telephone advice Reduced user conidence in 
tablet but no impact on use.
Use patients’ own equipment. Use a basic 
tablet that only displays the TiM app.
  User fear of ‘breaking’ 
the tablet
Face-to-face training 
to improve user 
conidence
Patients/carers reluctant to 
use the additional features 
on the tablet.
Use patients’ own equipment.
Face-to-face training.
Internet connection
  Poor 3G phone signal Used patients’ own 
broadband
None: solution found for all 
patients (3G or patients’ own 
broadband)
Use patients’ own broadband. Check 
internet availability prior to TiM enrolment.
  Patients switched Wi-
Fi off
Home visit required Several TiM sessions failed 
to download.
Monitor adherence. Alert team if adherence 
is low.
  Unreliable connection 
between scales and 
tablet/broadband
A separate 3G Wi-Fi 
route provided (‘Mii’). 
No solution if using 
broadband
Additional home visits 
required and loss of weight 
data for several weeks.
Manual weight recording. Avoid using 
peripheral devices.
Clinician portal
  Password/login 
problems
Support by external IT 
team
Delayed access during MDC 
visit.
Local systems access support.
MDC, multidisciplinary clinic; TiM, telehealth in motor neuron disease.
gave was also a disincentive to use TiM, particularly when 
they were expecting feedback.
‘It’s like all surveys… they say “your opinion is im-
portant…” You say something absolutely and nobody 
comes back to you. And you think: well how import-
ant is that survey?’ Carer 228
The use of the additional features of the tablet (the 
educational messages, knowledge centre or problem list) 
was not monitored during the trial. Unlike the main TiM 
app, participants reported that they were less likely to use 
these. Most were aware of these resources, particularly 
the short messages that appear while completing the TiM 
questions. Some participants reported reading some of 
the additional material, but no one felt strongly that these 
had had a major positive impact with only half agreeing 
that they were useful (figure 1).
Participants’ attitudes towards TiM
(Online supplementary data file tables 7–11)
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Figure 1 Patient and carer satisfaction with TiM telehealth at 6 months. MND, motor neuron disease; TiM, telehealth in motor 
neuron disease.
Figure 2 A visual representation of individual patient adherence over the duration of the trial. Each black dot indicates a 
completed TiM session. A coloured dot indicates the end of follow-up. TiM, telehealth in motor neuron disease.
Fourteen (87%) patients and carers agreed that TiM 
questions were relevant to them and 12 (73%) patients 
and carers felt able to report all the problems they expe-
rienced using TiM (figure 1). Thirteen (80%) patients 
and 12 (73%) carers would use it again. Fourteen (87%) 
patients and 12 (73%) carers would recommend it to 
another patient.
‘I think it’s probably one of the best ideas to come out 
of the NHS for years.’ Patient 122
Participants did not find using TiM intrusive or upset-
ting. They explained they were reminded about their 
disease everyday already and knew themselves if they had 
deteriorated without using the TiM.
‘It doesn’t bother me. When I was first diagnosed I 
was not keen on talking about it. I’ve since got better 
and I think that helps. I’m quite happy to be remind-
ed. I think you are reminded every day. That tablet 
makes no difference to that.’ Patient 381
Some participants thought the questions were repeti-
tive, particularly carers. Some noticed they reported the 
same problems every week. Some felt the questions were 
insufficiently sensitive to reflect the day-to-day fluctuation 
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Figure 3 A visual representation of individual carer adherence over the duration of the trial. Each black dot indicates a 
completed TiM session. A coloured dot indicates the end of follow-up. TiM, telehealth in motor neuron disease.
in their condition. One carer suggested that the questions 
should use other ways to assess carers lives more critically, 
which could be used to encourage carers to consider their 
own well-being and adopt coping strategies.
Clinicians experiences using TiM
(Online supplementary data file tables 12–13)
The telehealth nurse said that using the clinical 
portal was ‘very, very easy’, taking ‘minutes’ per use. She 
explained that initially she looked at the system every day 
but by the end of the trial she looked weekly and some-
times a little less often. She would look at each patient 
but focused on new and changing alerts. She explained 
that if she saw a patient/carer’s answer was associated 
with a green flag it indicated everything was ‘ok’, orange 
meant ‘there’s maybe some elements that might need to 
be looked at’, while a red flag indicated a problem.
Safety and accuracy of TiM
No adverse events related to TiM were reported, and no 
participant reported delaying seeking medical attention 
as a result of TiM. Thirty-eight clinician satisfaction forms 
were completed when patients using TiM attended clinic. 
All agreed that TiM gave a useful and accurate picture 
of the patient’s and carer’s condition and was a positive 
influence on the consultation. However, 20 (54%) were 
completed by the investigator (EH) who saw the patient 
in clinic, 18 (46%) were completed by other physicians.
The reported potential impacts of TiM
(Online supplementary data file tables 14, 15)
Reported potential impacts included improved moni-
toring and communication with the clinical team and 
improved effectiveness of MDC visits and care coordina-
tion. Other potential impacts included improved patient 
awareness of their disease and the ability to identify carer 
distress.
Improving links with the clinical team
Participants thought TiM could provide a ‘direct link’ with 
the care team, increasing monitoring, providing better 
connection with specialists and enabling earlier identifi-
cation of problems. Participants (particularly carers) also 
felt reassured that they were being thoroughly monitored. 
Reassurance was particularly beneficial for those who had 
infrequent contact with clinicians, either because they 
were early in the disease or were progressing slowly.
‘Patient: … for the first year no day was normal… You 
imagine symptoms, … you think…that must be relat-
ed to the MND…?
Interviewer: Do you think there might have been a 
point in your disease where those questions …were 
useful?
Patient: Nearer the beginning, definitely…If I could 
have camped in (neurologist)’s house for the first 
six months I would have done, just so she was there, so 
I could say; “but what about this, what about that?”… 
in the first year I would have filled that in every day, 
just to have that touch point’ Patient 047
Improved awareness of the disease
Many participants thought that TiM improved their 
awareness of their condition. They felt that they did not 
need to track their progress using TiM as they knew them-
selves how they were changing, but some had become 
more aware of their weight and nutrition. Rapid progres-
sion was something all patients feared, so those with 
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Figure 4 The ‘heat map’ for Patient 409. This is a screenshot from the clinical portal. The heat map reports the highest level 
lag for each section of the questionnaire (mobility, bulbar, breathing, well-being, nutrition) at each week. This indicates the 
patient has red and amber lags for both bulbar and later mobility. Below is the weight compared with the patients’ weight at 
baseline demonstrating a greater than 15% weight loss.
slowly progressive disease noticed that their answers did 
not change rapidly. This made them feel more positive.
early identiication of problems
The telehealth nurse described TiM as ‘a tool to aid the 
patient and then aid the nurse’. She could use TiM to 
gain more information and alert her earlier to problems. 
In one example, the TiM detected that one patient’s 
condition was declining quickly and the carer reported 
high levels of strain. The couple was struggling to accept 
his decline, and the patient tried to minimise his symp-
toms. TiM alerted the telehealth nurse to this patient’s 
rapidly declining weight and bulbar function (figure 4). 
She contacted him, discussed this information and 
encouraged him to consider gastrostomy insertion, which 
he accepted. He was asked about whether TiM affected 
this decision and explained that the information had 
been helpful:
‘The questions nudged me to facing what I could do 
and not what I can’t…I was frightened by the speed 
of loss of weight but was convinced how much muscle 
I lost. [sic]’ Written quote Patient 409
Other patients had reported problems on the app that 
they had not disclosed to their care team. The telehealth 
and community nurse speculated that this was because 
the patients were struggling to accept the change in their 
disease or the need for treatment and might have felt that 
they can be more honest using technology. They found 
this information useful to gain a more complete picture 
of the situation.
Improving the MDC
The telehealth nurse and physicians suggested that TiM 
could improve the MDC. The telehealth nurse said if 
TiM could reduce the burden faced by patients attending 
clinic, it would be welcomed by nurses. Potential benefits 
included facilitating sharing of information, collecting 
information and identifying problems before the visit. 
This could help plan the MDC visit to address the perti-
nent issues, shorten the time spent in hospital and make 
telephone appointments easier and a better alternative to 
face-to-face.
After seeing patients in their clinic using TiM, clini-
cians completed a feedback form (Shadow monitoring 
protocol). Twenty-three forms were completed. On 19 
(79%) occasions, clinicians agreed that the information 
gathered by TiM could be used to make appropriate 
decisions without the patient attending in person. After 
4 (17%) appointments, they answered ‘neutral’. Four-
teen (93%) patients said they would use TiM if they were 
unable to travel to clinic and 11 (73%) felt that they 
would be happy to have their appointment delayed if the 
doctor felt they were stable. Three (20%) were unsure 
and one (7%) disagreed. When interviewed, participants 
thought that the individual should choose how they used 
TiM depending on their needs, preferences and speed of 
progression. Some patients who were progressing slowly 
did not feel frequent MDCs were valuable. They were 
happy to use TiM and reduce the frequency of appoint-
ments as long as they could access the team quickly if 
required. Others wanted to attend the MDC to receive 
psychological support or address their problems and 
did not want to reduce visits. Some were not keen on 
telephone appointments, particularly when discussing 
sensitive matters or when they had speech difficulties. 
Similarly, the telehealth nurse explained face-to-face 
meetings helped her develop her relationship and gain 
information about the patient and carer. She felt some 
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aspects of their care would need a combination of TiM 
system and communication with the patients/carers and 
other members of the MDT. Both clinicians and patients 
identified the need for face-to-face consultation to fully 
evaluate respiratory symptoms.
Impact on carers
Carers felt that their well-being was directly linked to 
the patients’ well-being: interventions that improved 
the patient’s life or carer’s ability to provide care could 
improve a carer’s well-being. Carers felt reassured that 
their loved one was being monitored and that problems 
could be identified and solved more rapidly.
‘I think the benefit to (patient) is real. Because … 
somebody is there on hand looking at things…
Because it’s slow with P and he doesn’t need as much 
attention and care, it’s easy to feel detached from any 
positive interaction. Whereas with (TiM), you know 
somebody’s there and if there was something you’d 
pick up quite quickly as apposed to, waiting until your 
next twelve week appointment’ Carer 122
Carers and the telehealth nurse reported that the infor-
mation highlighted by TiM system could help couples 
accept the diagnosis and the problems they were facing 
and enable them to look positively towards receiving 
additional medical and social care. Carers reported that 
TiM prompted them to consider their own well-being and 
consider help if they were experiencing difficulties. They 
explained that usually the patient was present in meet-
ings and healthcare professionals tended to focus on 
the patient’s needs. This meant it was difficult for them 
to discuss their own concerns because of the potential 
impact this may have on the patient. Carers thought that 
TiM provided an opportunity for them to express their 
feelings in private, separately from the patient but still 
in the convenience of the home environment, without 
having to leave the patient. The impersonal nature of 
TiM was also an advantage as it enabled carers to be more 
honest about their difficulties.
‘I think it’s a really good way of doing it. Because 
whereas I probably try and flower things up a lot of 
the time …I found that, because it was just me and 
the tablet and I was able just to be totally honest 
about how I was… feeling at that particular time… 
The impersonal format… of the way it was actually 
done… for me, has been a real help just to be able… 
to do that.’ Carer 409
Problems with TiM
(Online supplementary data file tables 16–18)
While the participants did react positively to TiM, 
many felt it had not had a significant impact on their 
care. At 6 months, only seven (47%) patients and five 
(33%) of carers agreed, ‘The MND team contacted me 
quickly if my condition changed or I had a problem’. 
In some cases, participants felt their condition had not 
changed during the trial so TiM had not highlighted any 
problems. In other cases, problems were reported and 
help was offered but declined either because the partic-
ipant did not want it or because they did not think the 
MDT could help. However, the main explanation for this 
perceived lack of impact related to the large number of 
alerts generated by TiM, the way in which the telehealth 
nurse acted on information and lack of interaction 
between the participants and the telehealth nurse when 
problems occurred.
TiM system alerts
Of the total 585 TiM sessions completed, only 19 (3%) of 
all the patient/carer sessions return answers all of which 
were flagged as green. Three hundred and twenty-two 
(55%) sessions contained answers that generated at 
least one red flag and 244 (42%) generated amber alerts 
(figure 5A). We analysed individual answers and clinical 
notes for 10 randomly selected patients (334 sessions). 
Bulbar questions caused most red alerts (usually due to 
swallowing difficulties or excessive saliva), followed by 
limb function (usually due to falls) and respiratory symp-
toms. In the 334 sessions analysed, we identified 99 notes 
made by clinicians. Thirty-two (32%) notes reported the 
telehealth nurse taking action (figure 5B): commonly 
providing telephone advice or liaising with the MDT 
to share information and coordinate care. Seventeen 
(17%) times she planned to review the problem when the 
patient next came to clinic. In over half of occasions, the 
telehealth nurse documented that she took no action and 
in only 18 (18%) occasions did she contact the patient 
or carer. She explained that she usually took no action 
because she already was aware of the problem, the partic-
ipant was awaiting treatment or had declined to accept 
the recommended treatment/advice. She felt that she 
was seeing the same problems repeatedly. This was partic-
ularly frustrating when she had already taken action or 
when she felt there was no action required. While she did 
not feel TiM took up a lot of her time, these multiple 
problems for which she saw no solution caused an 
element of psychological burden. She could not control 
how the alerts were generated and would prefer to be 
able to ‘pause’ these alerts.
Patient-nurse interaction and feedback
Some participants recalled the telehealth nurse contacting 
them after reporting a problem on the TiM. The nurse 
would usually offer reassurance or new advice. While 
the telehealth nurse felt that these interactions did not 
have an impact, in the face of a relentlessly progressing 
disease, these interactions were welcomed by patients and 
carers and it reinforced their perception that specialists 
were monitoring them closely.
Patient…I did the second questionnaire, and within a 
day [Telehealth nurse] called.
Interviewer: Were you expecting her to call?
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Figure 5 (A) (left) The frequency of lags generated by the TiM sessions. The total sessions report the frequency of ‘top level’ 
lag (green, amber, red) for all 585 sessions completed. Below are the frequencies of ‘section lags’ generated by 10 patients 
who completed a total of 334 sessions. (B) (right) Actions described in 99 clinical notes. C, carer; MDT, multidisciplinary team; P, 
patient; TiM, telehealth in motor neuron disease; TN, telehealth nurse.
Patient: No, I wasn’t actually. It was just a bolt out of 
the blue…I find that quite positive. It shows that the 
whole idea of it works.’ Patient 122
The telehealth nurse prioritised problems that were 
unexpected and placed less priority on problems she 
expected to occur in MND. Contacting the patient 
depended on whether the problem needed or had a 
solution.
‘She red flagged that she’d fallen, which is quite a 
common occurrence on a lot of patients, and I don’t 
particularly worry unless they’ve been very, very well 
and then suddenly.’ Telehealth nurse
Problems the nurse perceived not to be significant 
were often felt to be important to patients and carers. For 
them, acknowledgement was helpful, even if no solution 
was needed.
‘Patient: (falls) … knocks your confidence …I prob-
ably were putting too much onus on (the hospital 
MDC) because (laughs) we’ve got this and there’s not 
(much) they can really do about this and we know 
that…
Interviewer: But that kind of acknowledgement’s 
quite important?
Carer: I do, yeah, it’s a bit of support, in’t it, it’s know-
ing that somebody else is in your corner.’ Carer 423
The telehealth nurse found it easier to manage patients 
and carers whom she already knew well. She developed 
relationships through hospital visits and a telephone 
helpline and through liaison with the community MDT. 
When the telehealth nurse had less knowledge of the 
patient, it could be more difficult to interpret the infor-
mation from TiM and liaison with the MDT was less easy. 
She also explained that she often did not know carers 
well and sometimes felt there were less obvious solutions 
to carer distress making her reluctant to telephone. In 
contrast, most carers felt extremely positive that the nurse 
provided vital counselling and advice.
The telehealth nurse felt that a more formalised 
protocol, outlining how she should respond to alerts, 
would likely increase the number of telephone calls made 
to patients. However, she felt it was important that she 
could use her knowledge and experience to decide how 
to respond to the information presented and would find 
it difficult working to an overly prescriptive protocol.
Improvements made to TiM during trial
Additional questions were added to the patient app: these 
recorded bladder and bowel symptoms and recorded 
disease progression in those with more severe disability 
(using the ALSFRS-EX38). Participants felt it was very 
important that the information provided was accurate 
and sometimes wanted to give more information in their 
answers. A free text facility was added, but this was used 
very infrequently. We added a heat map (figure 4) to the 
clinical portal, which displayed a visual representation of 
patients’ answers over the previous 6 months. We added 
the ability for the telehealth nurse to temporarily pause 
alerts. The telehealth nurse found the heat map helpful 
to enable her to get an overview of things she thought 
were important, such as weight, and to see which category 
had changed. She also found the ability to pause alerts 
helpful.
Recommended improvements to TiM
(Online supplementary data file tables 20–22)
The most important improvement we identified was 
to facilitate communication between the nurse and 
the participants. Most participants did not want auto-
matic feedback on their progress from TiM: they could 
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judge their progress themselves. They were also worried 
how they would react to seeing objective measures of 
decline without any interpretation from their clinical 
team. However, many expected some feedback. The 
minimum expected was to know that their information 
had been received and reviewed and for their problems 
to be acknowledged in some way, even if no action was 
taken. Participants were asked about their preferences 
for communication. Telephone and face-to-face conver-
sations were felt to be important for sensitive or complex 
discussions.
‘I think it’s not personal… I’d rather see somebody 
or talk to somebody than, than read about it on a 
screen.’ Carer 366
Patients found email helped them communicate at 
their own pace. This was particularly helpful for those 
with speech problems where a phone call would be diffi-
cult. Participants were happy waiting for a definitive 
answer if they received an acknowledgement. Participants 
also thought TiM could be used to arrange appointments 
and other administrative matters and they were happy 
for their answers to be shared with other clinicians. The 
community MND nurse felt TiM information would be 
useful but the clinical portal would be difficult to access 
in the community without a computer. She also explained 
she was ‘not good with computers’, but would be happy 
receiving alerts and information from someone else.
DISCuSSIOn
This detailed study of a digitally enabled MND service 
confirmed TiM was acceptable and feasible for patients, 
carers and staff. Differences in outcomes between the two 
groups were not formally assessed; however, our findings 
suggest that the TiM was accurate and safe. The study also 
gained a deeper understanding of the potential value of 
TiM and the context in which benefits might be seen.39 We 
identified some key barriers and enablers to acceptance 
and use of telehealth, which are applicable to other digi-
tally enabled care systems. A key initial barrier for partici-
pants was their perceived ability to master the technology. 
However, uptake was good with most participants (even 
those with severe disabilities) finding that they were able 
to use the system and sustain a good level of TiM adher-
ence. The interviews suggested that this was because of 
the accessible software and face-to-face training provided. 
This is in contrast to other telehealth projects, which 
found acceptance and adherence were major barriers.40 
This study aligns with other evidence that suggests that 
patients have a positive attitude to digital products and, 
in the right setting, respond positively to digitally enabled 
care, as long as the service is accessible and continues to 
offer personal contact with healthcare professionals.41 42 
We recommend that new interventions should adopt our 
user-centred design process and offer additional support 
to those without confidence in technology to make the 
intervention accessible.
The potential impacts of digitally enabled care may 
differ depending on a patient’s needs. TiM offered those 
with early or slowly progressive disease reassurance, infor-
mation and the ability to remain in contact with the care 
team when they needed it as well as offering an alterna-
tive to clinic visits. Early identification and coordinated 
management of complications of the disease appear to 
be most valuable to those patients at a later stage of the 
disease or those with more rapidly changing disease. 
These factors may explain why MDC care improves 
survival. The study also highlighted the potential value of 
TiM to carers who could receive support separately from 
the patient, while still allowing them to fulfil their role 
as a carer. Patients and carers already use digital tech-
nology to seek reliable and relevant information in order 
to self-manage,41 and the TiM can be used to provide 
information and promote self-management and self-effi-
cacy (something that has a positive influence of patient 
quality of life43). This type of interaction also promotes 
good adherence to telehealth.44 It was therefore inter-
esting to find that participants in this study reported that 
they did not use the additional education services on TiM 
that frequently. This may be because many patients wish 
to deal with problems as they occur rather than learning 
extensively about their condition.41 Telehealth could 
address this by providing a more personalised informa-
tion resource, signposting to topics at pace appropriate 
for the user according to their circumstances and the 
answers they provide on TiM.
The main weakness of TiM was the mismatch between 
staff actions and the expectations of participants. This 
was due to lack of communication and high numbers of 
unnecessary alerts generated by TiM. MND progression 
is experienced as a series of losses,45 46 and it is important 
for staff to acknowledge these problems and recognise the 
value that interactions with clinicians offer to patients and 
carers. Remote technology risks disrupting the traditional 
way in which the nurse would gather information, develop 
relationships and respond to patient difficulties.47 There 
is a risk of care becoming less patient centre and patients 
becoming demoralised as the aims of patients/carers and 
the clinical team no longer align. We recommend care 
is taken to develop these interpersonal relationships and 
for staff to be aware of the potential pitfalls of remote 
management. Key improvements include improving the 
algorithms to reduce alerts, facilitating feedback and 
better communication between patients, carers and staff 
using technology (such as chat facilities, email or tele-
medicine) and better training of staff who are required to 
work in ways that differ from the traditional face-to-face 
model.
The key strength of this study was the depth in which 
we examined the processes occurring in order to explain 
not just what happened, but why events occurred and 
how TiM could be improved and implemented. However, 
this was a small study involving only one centre. As some 
patients died or withdrew early in the study, of the 20 
assigned the TiM a maximum of 17 patients were using 
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the TiM at any one time. Only a small number of clini-
cians, many of whom had been helped with the TiM 
development, were involved. In particular, only one 
telehealth nurse used TiM, and this study showed that 
clinicians’ behaviour clearly influences the way in which 
the intervention is delivered. In this case, a nurse who 
engaged more with the system may have resulted in better 
outcomes. Larger studies are needed to gain a true under-
standing of what would occur when the service is offered 
to all patients as ‘business as usual’, in different centres 
using different staff members. Other staff may behave 
differently, and our results are a reminder that the way 
they use the TiM warrants monitoring to ensure interven-
tion fidelity and safety. The other limitations of evaluating 
complex interventions such as telehealth in traditional 
trials are discussed in detail in the parallel paper.33 We 
recommend that future evaluations should retain the 
methods employed in this trial to understand processes in 
detail and examine implementation in different contexts, 
continuing to examine factors such as acceptability, adop-
tion, fidelity, safety, costs and sustainability.
COnCluSIOn
The TiM system was acceptable to patients and carers 
with good uptake and adherence. Key to its success will 
be continued user and staff engagement and ensuring 
the system complements the existing services. Improve-
ments to TiM should be based on the findings of this eval-
uation. Future process evaluations should also examine 
the implementation of TiM at other sites to determine 
whether the findings from this study can be generalised.
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